ArticlePharmaceuticals (Basel, Switzerland)2025

Central Insulin-like Growth Factor-1 Treatment Enhances Working and Reference Memory by Reducing Neuroinflammation and Amyloid Beta Deposition in a Rat Model of Sporadic Alzheimer's Disease.

Joanna Dunacka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.